1. Home
  2. REGN vs URI Comparison

REGN vs URI Comparison

Compare REGN & URI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REGN
  • URI
  • Stock Information
  • Founded
  • REGN 1988
  • URI 1997
  • Country
  • REGN United States
  • URI United States
  • Employees
  • REGN N/A
  • URI N/A
  • Industry
  • REGN Biotechnology: Pharmaceutical Preparations
  • URI Diversified Commercial Services
  • Sector
  • REGN Health Care
  • URI Consumer Discretionary
  • Exchange
  • REGN Nasdaq
  • URI Nasdaq
  • Market Cap
  • REGN 59.5B
  • URI 56.8B
  • IPO Year
  • REGN 1991
  • URI 1997
  • Fundamental
  • Price
  • REGN $560.00
  • URI $937.77
  • Analyst Decision
  • REGN Buy
  • URI Buy
  • Analyst Count
  • REGN 23
  • URI 12
  • Target Price
  • REGN $794.83
  • URI $859.92
  • AVG Volume (30 Days)
  • REGN 972.9K
  • URI 487.1K
  • Earning Date
  • REGN 10-30-2025
  • URI 10-22-2025
  • Dividend Yield
  • REGN 0.63%
  • URI 0.76%
  • EPS Growth
  • REGN 5.03
  • URI 2.05
  • EPS
  • REGN 39.67
  • URI 38.65
  • Revenue
  • REGN $14,214,200,000.00
  • URI $15,749,000,000.00
  • Revenue This Year
  • REGN N/A
  • URI $5.53
  • Revenue Next Year
  • REGN $4.86
  • URI $4.79
  • P/E Ratio
  • REGN $14.12
  • URI $24.27
  • Revenue Growth
  • REGN 5.38
  • URI 6.77
  • 52 Week Low
  • REGN $476.49
  • URI $525.91
  • 52 Week High
  • REGN $1,170.58
  • URI $980.53
  • Technical
  • Relative Strength Index (RSI)
  • REGN 46.27
  • URI 54.11
  • Support Level
  • REGN $552.98
  • URI $934.84
  • Resistance Level
  • REGN $570.76
  • URI $970.57
  • Average True Range (ATR)
  • REGN 15.16
  • URI 19.41
  • MACD
  • REGN -2.91
  • URI -4.93
  • Stochastic Oscillator
  • REGN 16.26
  • URI 19.40

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

About URI United Rentals Inc.

United Rentals is the world's largest equipment rental company, principally operating in the US and Canada. It has 16% share in a highly fragmented market serving general industrial (49%), commercial construction (46%), and residential construction (5%). The company operates a $21 billion fleet of equipment, including aerial platforms, forklifts, excavators, trucks, power generators, and various other materials serving local and national accounts from nearly 1,600 locations in North America and 100 abroad. It has pursued a strategy of bundling specialty rental capabilities to offer its customers more advanced solutions in addition to its core equipment rental business, supporting its ambitions to become a one-stop shop for customers and enhance and maintain its margin profile.

Share on Social Networks: